US Stock MarketDetailed Quotes

VRAX Virax Biolabs

Watchlist
  • 0.6772
  • -0.0025-0.37%
Close Apr 19 16:00 ET
  • 0.7100
  • +0.0328+4.84%
Post 17:14 ET
1.60MMarket Cap-192P/E (TTM)

Virax Biolabs Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2023
(FY)Mar 31, 2022
(FY)Mar 31, 2021
(FY)Mar 31, 2020
Total revenue
8.56K
0
23.97%123.82K
99.88K
Operating revenue
--8.56K
--0
23.97%123.82K
--99.88K
Cost of revenue
9.93K
0
146.19%133.25K
54.13K
Gross profit
-1.37K
0
-120.62%-9.43K
45.75K
Operating expense
230.59%5.73M
172.98%1.73M
-8.88%635.1K
696.99K
Selling and administrative expenses
310.35%5.33M
152.47%1.3M
-15.59%514.88K
--609.99K
-Selling and marketing expense
92.62%26.62K
-75.84%13.82K
643.86%57.2K
--7.69K
-General and administrative expense
312.69%5.31M
181.01%1.29M
-24.01%457.68K
--602.3K
Research and development costs
-8.45%397.11K
260.79%433.74K
38.19%120.22K
--87K
Operating profit
-230.67%-5.73M
-168.98%-1.73M
1.03%-644.54K
-651.24K
Net non-operating interest income expense
-0.19%-15.47K
46.10%-15.44K
68.42%-28.64K
-90.69K
Non-operating interest expense
0.19%15.47K
-46.10%15.44K
-68.42%28.64K
--90.69K
Other net income (expense)
38,674.50%290.47K
-383.08%-753
-89.23%266
2.47K
Other non- operating income (expenses)
38,674.50%290.47K
-383.08%-753
-89.23%266
--2.47K
Income before tax
-211.90%-5.46M
-160.04%-1.75M
9.00%-672.92K
-739.46K
Income tax
0
0
Net income
-211.90%-5.46M
-160.04%-1.75M
9.00%-672.92K
-739.46K
Net income continuous Operations
-211.90%-5.46M
-160.04%-1.75M
9.00%-672.92K
---739.46K
Minority interest income
99.34%-269
-87.15%-41.04K
24.44%-21.93K
-29.02K
Net income attributable to the parent company
-219.37%-5.46M
-162.50%-1.71M
8.37%-650.98K
-710.44K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-219.37%-5.46M
-162.50%-1.71M
8.37%-650.98K
-710.44K
Basic earnings per share
-239.46%-5.1
-162.50%-1.5024
8.37%-0.5723
-0.6246
Diluted earnings per share
-239.46%-5.1
-162.50%-1.5024
8.37%-0.5723
-0.6246
Dividend per share
Currency Unit
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
(FY)Mar 31, 2023(FY)Mar 31, 2022(FY)Mar 31, 2021(FY)Mar 31, 2020
Total revenue 8.56K023.97%123.82K99.88K
Operating revenue --8.56K--023.97%123.82K--99.88K
Cost of revenue 9.93K0146.19%133.25K54.13K
Gross profit -1.37K0-120.62%-9.43K45.75K
Operating expense 230.59%5.73M172.98%1.73M-8.88%635.1K696.99K
Selling and administrative expenses 310.35%5.33M152.47%1.3M-15.59%514.88K--609.99K
-Selling and marketing expense 92.62%26.62K-75.84%13.82K643.86%57.2K--7.69K
-General and administrative expense 312.69%5.31M181.01%1.29M-24.01%457.68K--602.3K
Research and development costs -8.45%397.11K260.79%433.74K38.19%120.22K--87K
Operating profit -230.67%-5.73M-168.98%-1.73M1.03%-644.54K-651.24K
Net non-operating interest income expense -0.19%-15.47K46.10%-15.44K68.42%-28.64K-90.69K
Non-operating interest expense 0.19%15.47K-46.10%15.44K-68.42%28.64K--90.69K
Other net income (expense) 38,674.50%290.47K-383.08%-753-89.23%2662.47K
Other non- operating income (expenses) 38,674.50%290.47K-383.08%-753-89.23%266--2.47K
Income before tax -211.90%-5.46M-160.04%-1.75M9.00%-672.92K-739.46K
Income tax 00
Net income -211.90%-5.46M-160.04%-1.75M9.00%-672.92K-739.46K
Net income continuous Operations -211.90%-5.46M-160.04%-1.75M9.00%-672.92K---739.46K
Minority interest income 99.34%-269-87.15%-41.04K24.44%-21.93K-29.02K
Net income attributable to the parent company -219.37%-5.46M-162.50%-1.71M8.37%-650.98K-710.44K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -219.37%-5.46M-162.50%-1.71M8.37%-650.98K-710.44K
Basic earnings per share -239.46%-5.1-162.50%-1.50248.37%-0.5723-0.6246
Diluted earnings per share -239.46%-5.1-162.50%-1.50248.37%-0.5723-0.6246
Dividend per share
Currency Unit USDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg